Source link : https://www.newshealth.biz/health-news/skipping-5-fu-bolus-enhances-chemo-tolerance-in-gi-cancers/
TOPLINE: Omitting the 5-fluorouracil (5-FU) bolus from multidrug regimens in patients with advanced gastrointestinal cancers reduces toxicities, such as cytopenia, and does not affect overall survival. METHODOLOGY: The National Comprehensive Cancer Network clinical practice guidelines for gastric cancer recommend 5-FU multidrug regimens, such as FOLFOX, FOLFIRI, and FOLFIRINOX, which involve a short intravenous bolus of […]
Author : News Health
Publish date : 2024-09-27 09:00:00
Copyright for syndicated content belongs to the linked Source.
inHealth